Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...
Goldman Sachs analyst Matthew Sykes downgraded Cytek Biosciences Inc (NASDAQ:CTKB) stock rating from Buy to Sell and reduced the price target to $4.50 from the previous $7.00. The downgrade reflects ...
Geneos Wealth Management Inc. purchased a new stake in shares of GSK plc (NYSE:GSK – Free Report) during the fourth quarter, ...
In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on Endeavour Mining (EDV – Research Report), with a ...
Berenberg Bank analyst Kerry Holford maintained a Hold rating on FRESNILLO (FNLPF – Research Report) yesterday and set a price target of ...